Hoth Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Hoth Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q3 2024.
  • Hoth Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.13M, a 2.18% decline year-over-year.
  • Hoth Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$7.51M, a 22% increase year-over-year.
  • Hoth Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.85M, a 31% increase from 2022.
  • Hoth Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$11.4M, a 20.6% increase from 2021.
  • Hoth Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.3M, a 98.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$7.51M -$2.13M -$45.5K -2.18% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$7.46M -$1.63M +$241K +12.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$7.7M -$2.04M +$143K +6.54% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$7.85M -$1.7M +$1.78M +51.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$9.62M -$2.09M +$558K +21.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$10.2M -$1.87M +$805K +30% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$11M -$2.18M +$388K +15.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$11.4M -$3.48M +$1.47K +0.04% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$11.4M -$2.64M +$652K +19.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$12M -$2.68M +$598K +18.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$12.6M -$2.57M +$1.69M +39.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$14.3M -$3.48M -$2.72M -360% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$11.6M -$3.3M -$1.18M -55.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$10.4M -$3.28M -$778K -31.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$9.63M -$4.26M -$2.44M -133% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$7.2M -$757K +$3.15M +80.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$10.4M -$2.12M -$421K -24.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$9.93M -$2.5M -$1.23M -97% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$8.7M -$1.83M -$997K -120% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$7.7M -$3.91M -$3.33M -569% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$4.38M -$1.7M -$1.08M -173% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$3.3M -$1.27M -$504K -66% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$2.8M -$829K -$302K -57.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$2.5M -$584K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$620K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$763K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$528K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.